Navigation Links
Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
Date:11/7/2013

ment, we also achieved strong financial results for the 2013 third quarter.  The more notable financial achievements include:

a. Record quarterly total revenue of $420,762
b. Record quarterly products and services revenue of $327,958
c. Record quarterly consumable products sales of $51,450
d. Record quarterly Shredder System sales of $50,480

We have now reported three consecutive quarters with total revenue exceeding the prior year period.  And with the strong start we have had in the first five weeks of Q4, we believe that Q4 2013 will be the fourth consecutive quarter that total revenue exceeds the prior year period. 

About Pressure BioSciences, Inc. Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT").  PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market.  PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions.  PBI currently focuses its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications.

Forward Looking StatementsThis press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Pressure BioSciences, Inc. to Discuss Third Quarter 2013 Financial Results and Provide a Business Update
2. Blood Pressure Monitoring Testing Market is Expected to Reach USD 3.7 Billion Globally in 2019: Transparency Market Research
3. Hazardous, High-Pressure and Explosive Conditions Are No Match for Swiss Jewel Sapphire Windows
4. Pressure BioSciences, Inc. to Discuss Second Quarter 2013 Financial Results and Provide a Business Update
5. China Medical Flat Panel Detector Market & Pressure Injector 2013 Research Reports Now Available at ReportsnReports.com
6. Using pressure to swell pores, not crush them
7. Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
8. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
9. High pressure gold nanocrystal structure revealed
10. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
11. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... IN (PRWEB) July 25, 2014 At ... (FAA) has granted a 60-day extension for the public ... the Special Rule for Model Aircraft established by Congress ... of 2012. The 60-day extension establishes the new deadline ... United States Department of Transportation/FAA notice published in the ...
(Date:7/24/2014)... July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the ... randomized, active control Phase 3 study of Zerenex (ferric ... for the treatment of hyperphosphatemia in patients with end-stage ... binding and iRon delivery with FErric CiTrate in EsrD) ... the American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... July 24, 2014 Gain recognition ... Supply Chain of the biotech industry. Nominations are ... Awards, brought to you by the Bio ... of supply chain management professionals for the past ... stakeholders of the Biotech industry – Manufacturers, Service ...
(Date:7/24/2014)... , July 24, 2014  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, announced today ... a presentation to investors on Tuesday, July 29, ...  The presentation will include an overview of Asterias, ... the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics at least ...
Breaking Biology Technology:FAA Grants Comment Extension at the Request of AMA 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Call for Submission: BSMA’s Supply Chain Management Innovation Awards 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 3Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4
... to continue integration and expansion of PFPA,s IT ... - SRA International, Inc.,(NYSE: SRX ), a ... solutions to government organizations and commercial clients,today announced ... the Pentagon Force,Protection Agency (PFPA) Life Safety Security ...
... 11, 2008 at 9:55 a.m. EST, CHICAGO, Nov. 4 ... that O.B. Parrish, the Company,s Chief,Executive Officer, and Donna Felch, ... Annual Global Investment Conference at 9:55,a.m. Eastern Time on November ... Palace Hotel in New York City., A live audio ...
... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today ... a pivotal (Phase II/III) randomized trial using ... with head and neck cancers. The decision ... the Company,s Board of Directors from the ...
Cached Biology Technology:SRA Awarded $56 Million Contract by Pentagon Force Protection Agency 2The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference 2The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference 3Oncolytics Biotech Inc. Announces Decision to Pursue Phase II/III Pivotal Clinical Trial 2
(Date:7/25/2014)... SPRINGS, Florida , July 25, 2014 ... as more consumers are turning to digital technology for ... Inc. (OTCBB: NXTD), Google Inc. (NASDAQ: GOOG ... Inc. (NYSE: V ), Apple Inc. (NASDAQ: ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication ...
(Date:7/24/2014)... 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced ... control Phase 3 study of Zerenex (ferric citrate), the ... treatment of hyperphosphatemia in patients with end-stage renal disease ... iRon delivery with FErric CiTrate in EsrD) was published ... Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... for food or commercial food sale, has been heavily ... of many species of primates and other mammals. ... of the species being consumed are birds, particularly large ... the meat made available for sale but the meat ... and brought to villages for consumption, we noted a ...
Breaking Biology News(10 mins):Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
... journals need to ensure that their peer reviewers act ... to new guidelines launched by the Committee on Publication ... Reviewers set out the basic principles and standards that ... "Peer review plays an important role in ...
... power grids is challenging because fluctuating wind speed and ... varying power demand, many wind-farm managers end up wasting ... through active control including fully stopping turbines ... the power grid from spikes in supply. In a ...
... in a particular cellular pathway are linked with bladder ... early online in CANCER , a peer- reviewed ... help improve bladder cancer screening and treatment. Alterations ... is important for various cellular processes, have been implicated ...
Cached Biology News:Committee on Publication Ethics launches ethical guidelines for peer reviewers 2Genetic alterations linked with bladder cancer risk, recurrence, progression, and patient survival 2